We are live on ! Find out more
PSTV icon

Plus Therapeutics
PSTV

4 hedge funds and large institutions have $4.53M invested in Plus Therapeutics in 2016 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 4 → 4 (0)

0% more ownership

Funds ownership: 0% → 0% (+0%)

27% less capital invested

Capital invested by funds: $6.25M → $4.53M (-$1.72M)

39% less call options, than puts

Call options by funds: $33K | Put options by funds: $54K

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
–
Calls
$33K
Puts
$54K
Net Calls
-$21K
Net Calls Change
-$39K

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$318K
2
PCMI
Princeton Capital Management Inc
New Jersey
-$58K
3
AIM
Acrospire Investment Management
Illinois
-$7K
4
JP Morgan Chase
JP Morgan Chase
New York
-$2K
5
KLI
Kelman-Lazarov Inc
Tennessee
-$1.59K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$2.49M – – –
PCM
2
Perkins Capital Management
Minnesota
$602K – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$424K -$318K -1 -50%
BIT
4
BlackRock Institutional Trust
California
$383K – – –
Creative Planning
5
Creative Planning
Kansas
$118K – – –
Geode Capital Management
6
Geode Capital Management
Massachusetts
$91K – – –
VKH
7
Virtu KCG Holdings
New York
$91K – – –
BFA
8
BlackRock Fund Advisors
California
$67K – – –
Citadel Advisors
9
Citadel Advisors
Florida
$56K – – –
Simplex Trading
10
Simplex Trading
Illinois
$39K – – –
Goldman Sachs
11
Goldman Sachs
New York
$27K – – –
Northern Trust
12
Northern Trust
Illinois
$27K – – –
Wolverine Trading
13
Wolverine Trading
Illinois
$21K – – –
California Public Employees Retirement System
14
California Public Employees Retirement System
California
$20K – – –
UB
15
UMB Bank
Missouri
$19K – – –
Renaissance Technologies
16
Renaissance Technologies
New York
$15K – – –
Royal Bank of Canada
17
Royal Bank of Canada
Ontario, Canada
$15K – – –
BIM
18
BlackRock Investment Management
Delaware
$5K – – –
New York State Common Retirement Fund
19
New York State Common Retirement Fund
New York
$5K – – –
BA
20
BlackRock Advisors
Delaware
$4K – – –
Morgan Stanley
21
Morgan Stanley
New York
$4K – – –
Barclays
22
Barclays
United Kingdom
$2K – – –
Bank of America
23
Bank of America
North Carolina
$1K – – –
Manulife (Manufacturers Life Insurance)
24
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1K – – –
UBS Group
25
UBS Group
Switzerland
$1K – – –
1
2

PSTV Hedge Fund Activity: Q4 2016 in Review

4 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Plus Therapeutics (PSTV) for Q4 2016, worth a combined $4.53M — down 27% from $6.25M a quarter earlier.

Fund positioning in PSTV was balanced in Q4 2016: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.

The largest seller was Vanguard Group, cutting an estimated $318K.

  • 4 institutional investors held Plus Therapeutics (PSTV) as of Q4 2016, unchanged from Q3 2016.
  • Funds reported $4.53M of Plus Therapeutics stock for Q4 2016, down 27% quarter-over-quarter.
  • 0 funds opened new Plus Therapeutics positions in Q4 2016 and 0 closed out.
  • The largest Plus Therapeutics seller in Q4 2016 was Vanguard Group, an estimated $318K sold.

Based on aggregated 13F filings for Q4 2016.